Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:
African American Hub News
 

Back to home » News & Views » Treatment News


 

December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007


emailrssprint

July 8, 2008

Fatty Liver Common in Patients With Metabolic Problems

Nonalcoholic Fatty Liver Disease (NAFLD)—a condition marked by chronic liver inflammation in people who drink little or no alcohol and who do not have viral hepatitis—was found in more than a third of HIV-positive patients being treated for metabolic disorders, say the authors of a study published in the July 15 issue of Clinical Infectious Diseases. Use of nucleoside reverse transcriptase inhibitors (NRTIs) was associated with an increased risk for NAFLD.

NAFLD can lead to permanent damage of the liver, liver failure and clogging of the arteries. This last element, atherosclerosis, is of particular interest to researchers, who believe that NAFLD may be an important early indicator of cardiovascular disease. Cardiovascular disease is a growing concern in HIV disease, as people with HIV have been found to have an increased risk of heart attacks. Both NAFLD and cardiovascular disease are more common in HIV-negative people with metabolic syndrome, a cluster of symptoms that include unhealthy changes to cholesterol levels and blood sugar, and the accumulation of fat in the gut area.

To determine the prevalence and risk factors of NAFLD in people with HIV, Giovanni Guaraldi, MD, of the University of Modena and Reggio Emilia School of Medicine, in Modena, Italy, and his colleagues enrolled 225 HIV-positive patients who had been referred to a clinic for metabolic disorders. Seventy-two percent of the patients were male, the average age was 48 and nearly two thirds were smokers. A diagnosis of NAFLD was made by interpreting the results of a computed axial tomography (CT) scan of the liver and spleen.

Guaraldi’s team diagnosed 37 percent of the patients with NAFLD, a far higher rate than was anticipated. The team also found that use of NRTIs was an independent risk factor for diagnosis of NAFLD, with an increased risk of 11 percent for each year that a person had been taking NRTIs.

The authors conclude that NAFLD may greatly increase the risk of cardiovascular disease in HIV-positive people, notably those with other risk factors including obesity, smoking, high cholesterol and diabetes.

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

         


[Go to top]


Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Blogs by African-Americans
Antonia
Felipe
Jeanette
Pinnace
Kate
Ferguson

Read the blogs
Overheard in the Forums
"I'm HIV positive and diabetic (as well as have high cholesterol) and some of my meds specify taking them with 'high fat foods' which I have to do twice a day. I've eaten as healthy as possible, but when it comes to high fat foods, I am in a quandary...about what to eat sometimes..."

from Nutrition & HIV


Join the forums

Real Health Poll
Question: How would you characterize your stress level at work?
Minimally stressful
Moderately stressful
Extremely stressful

Smart + Strong Network
POZ Magazine
POZ Personals
POZ Mentor
POZ ASO Directory
AIDSmeds
Real Health Magazine
TuSalud Magazine
ComboCards
Rx Info Cards
Also visit POZ on...
Facebook

MySpace

YouTube

[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy